Relationship between lysostaphin endopeptidase production and cell wall composition in Staphylococcus staphylolyticus

Mutants of Staphylococcus staphylolyticus incapable of producing an extracellular staphylolytic glycylglycine endopeptidase were isolated and found to have cells in the population susceptible to lysis by this enzyme, as did the wild-type organism under conditions in which the endopeptidase was not produced. These results suggest that cultures of this organism normally contain a heterogeneous population of cells with regard to cell wall composition and susceptibility to the enzyme. Production of the endopeptidase appears to act as a selective pressure which removes the susceptible cells in the population as the enzyme appears in the medium. A comparison of the peptidoglycan of the wild-type organism grown under conditions in which the endopeptidase was produced with that of this organism grown under nonproducing conditions and with those of endopeptidase-less mutants showed that in the presence of the endopeptidase the cell population had peptidoglycan with shorter peptide cross bridges and a greater percentage of serine in these cross bridges than was found in cells grown in the absence of the enzyme. The inability of the endopeptidase to hydrolyze glycylserine and serylglycine peptide bonds suggests that at least part of the resistance this organism has to the endopeptidase is due to relative amounts of serine found in the peptide cross bridges of some cells in the population.

[1]  J. H. Lancaster,et al.  Lysostaphin endopeptidase-catalysed transpeptidation reactions of the imino-transfer type. , 1977, The Biochemical journal.

[2]  K. Schleifer,et al.  Isolation and Characterization of Staphylococci from Human Skin I. Amended Descriptions of Staphylococcus epidermidis and Staphylococcus saprophyticus and Descriptions of Three New Species: Staphylococcus cohnii, Staphylococcus haemolyticus, and Staphylococcus xylosus , 1975 .

[3]  E. Donegan,et al.  In Vitro Incorporation of Serine into the Staphylococcal Cell Wall , 1974, Infection and immunity.

[4]  K. Schleifer,et al.  Mode of Action of Glycine on the Biosynthesis of Peptidoglycan , 1973, Journal of bacteriology.

[5]  O. Iversen,et al.  Studies on lysostaphin. Separation and characterization of three enzymes. , 1973, European journal of biochemistry.

[6]  K. Schleifer,et al.  Peptidoglycan Types of Bacterial Cell Walls and Their Taxonomic Implications , 1973, Bacteriological reviews.

[7]  G. Coleman,et al.  A Rapid and Convenient Method for Determining the Dry Weight Content of Bacteria Which Show a Tendency to Form Large Aggregates , 1972 .

[8]  D. Tipper,et al.  Structures of the cell wall peptidoglycans of Staphylococcus epidermidis Texas 26 and Staphylococcus aureus Copenhagen. I. Chain length and average sequence of cross-bridge peptides. , 1969, Biochemistry.

[9]  W. Zygmunt,et al.  Optical configuration of staphylococcal cell wall serine , 1968, Journal of bacteriology.

[10]  W. Zygmunt,et al.  Susceptibility of coagulase-negative staphylococci to lysostaphin and other antibiotics. , 1968, Applied microbiology.

[11]  W. Zygmunt,et al.  Lytic action of lysostaphin on susceptible and resistant strains of Staphylococcus aureus. , 1967, Canadian journal of microbiology.

[12]  R. Z. Korman Elevated Cell Wall Serine in Pleiotropic Staphylococcal Mutants , 1966, Journal of bacteriology.

[13]  C. Schindler Staphylococcal Strains with Relation to Lysostaphin Sensitivity , 1966, Nature.

[14]  W. Kloos,et al.  A BIOCHEMICAL CHARACTERIZATION OF HISTIDINE-DEPENDENT MUTANTS OF STAPHYLOCOCCUS AUREUS. , 1965, Journal of general microbiology.

[15]  W. Zygmunt,et al.  LYSOSTAPHIN: ENZYMATIC MODE OF ACTION. , 1965, Biochemical and biophysical research communications.

[16]  C. Schindler,et al.  PURIFICATION AND PROPERTIES OF LYSOSTAPHIN--A LYTIC AGENT FOR STAPHYLOCOCCUS AUREUS. , 1965, Biochimica et biophysica acta.

[17]  C. Schindler,et al.  LYSOSTAPHIN: A NEW BACTERIOLYTIC AGENT FOR THE STAPHYLOCOCCUS. , 1964, Proceedings of the National Academy of Sciences of the United States of America.

[18]  E. F. Harrison,et al.  THE IN VITRO EFFECT OF LYSOSTAPHIN ON CLINICAL ISOLATES OF STAPHYLOCOCCUS AUREUS. , 1964, Canadian journal of microbiology.